Skip to Main Content
Try STAT+ TODAY
Trending:
The Obesity Revolution
STAT+
Health
Biotech
Subscribe Now To access exclusive content, subscribe to STAT+
View Latest View the latest STAT+ stories
Politics
STAT+

Facing progressive pressure, Pelosi could expand her drug pricing plan to negotiate prices for $118 billion worth of medicines

  • Lev Facher

By Lev Facher June 14, 2019

Reprints
Nancy Pelosi
House Speaker Nancy Pelosi (D-Calif.) Mark Wilson/Getty Images

WASHINGTON — Progressive lawmakers this week exacted a major concession from House Speaker Nancy Pelosi: a pledge for the federal government to negotiate prices for a far larger group of drugs than initially proposed.

The new plan, confirmed to STAT by Democratic aides, would have the federal government negotiate for the price of at least 250 drugs covered by Medicare — compared to at least 25 drugs in the initial proposal.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED

About the Author Reprints

Lev Facher

Lev Facher

Addiction Reporter

Lev Facher covers the U.S. addiction and overdose crisis.

Tags

FDA advisory panel recommends conditional approval of Biogen’s drug…
FDA advisory panel recommends conditional approval of Biogen’s drug for rare form of ALS
Researchers devise new strategies to overcome a key CRISPR…
Researchers devise new strategies to overcome a key CRISPR flaw
Why fentanyl is deadlier than heroin, in a single…
Why fentanyl is deadlier than heroin, in a single photo
Key senators blast Medicare Advantage insurers for ‘exorbitant salaries,’…
Key senators blast Medicare Advantage insurers for ‘exorbitant salaries,’ ‘massive payouts’ to execs
Former surgeon general Jerome Adams tries to outrun the…
Former surgeon general Jerome Adams tries to outrun the shadow of the president he served
FDA advisory panel recommends conditional approval of Biogen’s drug…
FDA advisory panel recommends conditional approval of Biogen’s drug for rare form of ALS

Recommended Stories